Biosurgery Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Significant Rise in the Aging Population, Coupled with Increasing Government Support
   3. Market Restraints
      1. High Cost of Biosurgery
      2. Shortage of Skilled Healthcare Professionals
   4. Market Opportunity
      1. Technological advancements in Home Care Device
   5. Market Trends
      1. Growth of Home-Based and Community Care Services
      2. Integration of Telehealth and Digital Health Platforms
5. MARKET SEGMENTATION
   1. By Products
      1. Bone-Graft Substitutes
      2. Soft-Tissue Attachments
      3. Haemostatic Agents
      4. Surgical Sealants and Adhesives
      5. Adhesion Barriers
      6. Staple-Line Reinforcement Agents
   2. By Application
      1. Paediatrics
      2. Adults
      3. Elderly
   3. By End User
      1. Hospitals
      2. Clinics
      3. Others
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Aroa Biosurgery Limited (New Zealand)
      2. Baxter (US)
      3. B. Braun Melsungen AG (Germany)
      4. CryoLife, Inc. (US)
      5. BD (US)
      6. CSL Limited (Australia)
      7. Exactech, Inc. (US)
      8. Getinge AG (Sweden)
      9. Hemostasis, LLC (US)
      10. Integra LifeSciences Corporation (US)
      11. Johnson & Johnson Services, Inc. (US)
      12. Medtronic (US)
      13. Osiris Therapeutics, Inc. (US)
      14. Pfizer Inc. (US)
      15. RTI Surgical Holdings, Inc. (US)
      16. Sanofi (France)
      17. Stryker Corporation (US)
      18. Samyang Holdings Corporation. (US)
      19. TELA Bio, Inc. (US)
      20. Tissue Regenix (UK)
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global Biosurgery market?

The global market of biosurgeryis projected to reach USD 23.23 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Biosurgery market?

The global biosurgerymarket has an estimated annual growth rate of 5.5%.

Q.3. What are the recent trends of Biosurgery market?

Integration of digital technologies and robotics and personalized medicine and customized solutionsare some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Biosurgery?

The major companies profiled in this report include AROA BIOSURGERY LIMITED (New Zealand), Baxter (US), B. Braun Melsungen AG (Germany), CryoLife, Inc. (US), BD (US), CSL Limited (Australia), Exactech, Inc. (US), Getinge AG (Sweden), Hemostasis, LLC (US), Integra LifeSciences Corporation (US), Johnson & Johnson Services, Inc. (US), Medtronic (US), Osiris Therapeutics, Inc. (US), Pfizer Inc. (US), RTI Surgical Holdings, Inc. (US), Sanofi (France), Stryker Corporation (US), SAMYANG HOLDINGS CORPORATION. (US), TELA Bio, Inc. (US), Tissue Regenix (UK)., among others.  

Q.5. Which is the largest regional market in the Biosurgery?

North America is the largest regional market for biosurgery.